211 related articles for article (PubMed ID: 36508697)
1. Genome-Wide Association Study Identifies
Wang X; Singh P; Zhou L; Sharafeldin N; Landier W; Hageman L; Burridge P; Yasui Y; Sapkota Y; Blanco JG; Oeffinger KC; Hudson MM; Chow EJ; Armenian SH; Neglia JP; Ritchey AK; Hawkins DS; Ginsberg JP; Robison LL; Armstrong GT; Bhatia S
J Clin Oncol; 2023 Mar; 41(9):1758-1769. PubMed ID: 36508697
[TBL] [Abstract][Full Text] [Related]
2. CELF4 Variant and Anthracycline-Related Cardiomyopathy: A Children's Oncology Group Genome-Wide Association Study.
Wang X; Sun CL; Quiñones-Lombraña A; Singh P; Landier W; Hageman L; Mather M; Rotter JI; Taylor KD; Chen YD; Armenian SH; Winick N; Ginsberg JP; Neglia JP; Oeffinger KC; Castellino SM; Dreyer ZE; Hudson MM; Robison LL; Blanco JG; Bhatia S
J Clin Oncol; 2016 Mar; 34(8):863-70. PubMed ID: 26811534
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the children's oncology group.
Wang X; Liu W; Sun CL; Armenian SH; Hakonarson H; Hageman L; Ding Y; Landier W; Blanco JG; Chen L; Quiñones A; Ferguson D; Winick N; Ginsberg JP; Keller F; Neglia JP; Desai S; Sklar CA; Castellino SM; Cherrick I; Dreyer ZE; Hudson MM; Robison LL; Yasui Y; Relling MV; Bhatia S
J Clin Oncol; 2014 Mar; 32(7):647-53. PubMed ID: 24470002
[TBL] [Abstract][Full Text] [Related]
4. Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline-Induced Cardiomyopathy - A COG-ALTE03N1 Report.
Singh P; Shah DA; Jouni M; Cejas RB; Crossman DK; Magdy T; Qiu S; Wang X; Zhou L; Sharafeldin N; Hageman L; McKenna DE; Armenian SH; Balis FM; Hawkins DS; Keller FG; Hudson MM; Neglia JP; Ritchey AK; Ginsberg JP; Landier W; Bhatia R; Burridge PW; Bhatia S
J Am Heart Assoc; 2023 Oct; 12(19):e029954. PubMed ID: 37750583
[TBL] [Abstract][Full Text] [Related]
5. Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.
Blanco JG; Sun CL; Landier W; Chen L; Esparza-Duran D; Leisenring W; Mays A; Friedman DL; Ginsberg JP; Hudson MM; Neglia JP; Oeffinger KC; Ritchey AK; Villaluna D; Relling MV; Bhatia S
J Clin Oncol; 2012 May; 30(13):1415-21. PubMed ID: 22124095
[TBL] [Abstract][Full Text] [Related]
6. Association of GSTM1 null variant with anthracycline-related cardiomyopathy after childhood cancer-A Children's Oncology Group ALTE03N1 report.
Singh P; Wang X; Hageman L; Chen Y; Magdy T; Landier W; Ginsberg JP; Neglia JP; Sklar CA; Castellino SM; Dreyer ZE; Hudson MM; Robison LL; Blanco JG; Relling MV; Burridge P; Bhatia S
Cancer; 2020 Sep; 126(17):4051-4058. PubMed ID: 32413235
[TBL] [Abstract][Full Text] [Related]
7. Gene-Level Analysis of Anthracycline-Induced Cardiomyopathy in Cancer Survivors: A Report From COG-ALTE03N1, BMTSS, and CCSS.
Sharafeldin N; Zhou L; Singh P; Crossman DK; Wang X; Hageman L; Landier W; Blanco JG; Burridge PW; Sapkota Y; Yasui Y; Armstrong GT; Robison LL; Hudson MM; Oeffinger K; Chow EJ; Armenian SH; Weisdorf DJ; Bhatia S
JACC CardioOncol; 2023 Dec; 5(6):807-818. PubMed ID: 38205005
[TBL] [Abstract][Full Text] [Related]
8. Candidate Plasma Biomarkers to Detect Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors: A Case Control Study in the Dutch Childhood Cancer Survivor Study.
Leerink JM; Feijen EAM; Moerland PD; de Baat EC; Merkx R; van der Pal HJH; Tissing WJE; Louwerens M; van den Heuvel-Eibrink MM; Versluys AB; Asselbergs FW; Sammani A; Teske AJ; van Dalen EC; van der Heiden-van der Loo M; van Dulmen-den Broeder E; de Vries ACH; Kapusta L; Loonen J; Pinto YM; Kremer LCM; Mavinkurve-Groothuis AMC; Kok WEM
J Am Heart Assoc; 2022 Jul; 11(14):e025935. PubMed ID: 35861824
[TBL] [Abstract][Full Text] [Related]
9. Genetic Variants Associated with Therapy-Related Cardiomyopathy among Childhood Cancer Survivors of African Ancestry.
Sapkota Y; Qin N; Ehrhardt MJ; Wang Z; Chen Y; Wilson CL; Estepp J; Rai P; Hankins JS; Burridge PW; Jefferies JL; Zhang J; Hudson MM; Robison LL; Armstrong GT; Mulrooney DA; Yasui Y
Cancer Res; 2021 May; 81(9):2556-2565. PubMed ID: 33288658
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel hypermethylated or hypomethylated CpG sites and genes associated with anthracycline-induced cardiomyopathy.
Singh P; Zhou L; Shah DA; Cejas RB; Crossman DK; Jouni M; Magdy T; Wang X; Sharafeldin N; Hageman L; McKenna DE; Horvath S; Armenian SH; Balis FM; Hawkins DS; Keller FG; Hudson MM; Neglia JP; Ritchey AK; Ginsberg JP; Landier W; Burridge PW; Bhatia S
Sci Rep; 2023 Aug; 13(1):12683. PubMed ID: 37542143
[TBL] [Abstract][Full Text] [Related]
11. Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients.
Ruiz-Pinto S; Pita G; Martín M; Alonso-Gordoa T; Barnes DR; Alonso MR; Herraez B; García-Miguel P; Alonso J; Pérez-Martínez A; Cartón AJ; Gutiérrez-Larraya F; García-Sáenz JA; Benítez J; Easton DF; Patiño-García A; González-Neira A
Breast Cancer Res Treat; 2018 Jan; 167(1):249-256. PubMed ID: 28913729
[TBL] [Abstract][Full Text] [Related]
12. Exposure to anthracyclines during childhood causes cardiac injury.
Lipshultz SE
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer.
Blanco JG; Leisenring WM; Gonzalez-Covarrubias VM; Kawashima TI; Davies SM; Relling MV; Robison LL; Sklar CA; Stovall M; Bhatia S
Cancer; 2008 Jun; 112(12):2789-95. PubMed ID: 18457324
[TBL] [Abstract][Full Text] [Related]
14. Derivation of Anthracycline and Anthraquinone Equivalence Ratios to Doxorubicin for Late-Onset Cardiotoxicity.
Feijen EAM; Leisenring WM; Stratton KL; Ness KK; van der Pal HJH; van Dalen EC; Armstrong GT; Aune GJ; Green DM; Hudson MM; Loonen J; Oeffinger KC; Robison LL; Yasui Y; Kremer LCM; Chow EJ
JAMA Oncol; 2019 Jun; 5(6):864-871. PubMed ID: 30703192
[TBL] [Abstract][Full Text] [Related]
15. The genetic underpinnings of anthracycline-induced cardiomyopathy predisposition.
Berkman AM; Hildebrandt MAT; Landstrom AP
Clin Genet; 2021 Aug; 100(2):132-143. PubMed ID: 33871046
[TBL] [Abstract][Full Text] [Related]
16. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
Sieswerda E; van Dalen EC; Postma A; Cheuk DK; Caron HN; Kremer LC
Cochrane Database Syst Rev; 2011 Sep; (9):CD008011. PubMed ID: 21901716
[TBL] [Abstract][Full Text] [Related]
17. Haptoglobin Gene Expression and Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors: A COG-ALTE03N1 Report.
Singh P; Crossman DK; Zhou L; Wang X; Sharafeldin N; Hageman L; Blanco JG; Burridge PW; Armenian SH; Balis FM; Hawkins DS; Keller FG; Hudson MM; Neglia JP; Ritchey AK; Ginsberg JP; Landier W; Bhatia S
JACC CardioOncol; 2023 Jun; 5(3):392-401. PubMed ID: 37397079
[TBL] [Abstract][Full Text] [Related]
18. Cardiac toxicity after anthracycline chemotherapy in childhood.
Iarussi D; Indolfi P; Galderisi M; Bossone E
Herz; 2000 Nov; 25(7):676-88. PubMed ID: 11141677
[TBL] [Abstract][Full Text] [Related]
19. Late-onset cardiomyopathy among survivors of childhood lymphoma treated with anthracyclines: a systematic review.
Benetou DR; Stergianos E; Geropeppa M; Ntinopoulou E; Tzanni M; Pourtsidis A; Petropoulos AC; Georgakis MK; Tousoulis D; Petridou ET
Hellenic J Cardiol; 2019; 60(3):152-164. PubMed ID: 30273645
[TBL] [Abstract][Full Text] [Related]
20. Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure.
Schneider BP; Shen F; Gardner L; Radovich M; Li L; Miller KD; Jiang G; Lai D; O'Neill A; Sparano JA; Davidson NE; Cameron D; Gradus-Pizlo I; Mastouri RA; Suter TM; Foroud T; Sledge GW
Clin Cancer Res; 2017 Jan; 23(1):43-51. PubMed ID: 27993963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
